Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Long-Term Deferred Tax (2023 - 2025)

Outset Medical (OM) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $260.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 6.29% to $260.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $260.6 million, a 6.29% increase, with the full-year FY2025 number at $260.6 million, up 6.29% from a year prior.
  • Long-Term Deferred Tax was $260.6 million for Q4 2025 at Outset Medical, up from $245.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $260.6 million in Q4 2025 to a low of $223.4 million in Q4 2023.
  • A 3-year average of $243.0 million and a median of $245.2 million in 2024 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: grew 9.74% in 2024, then rose 6.29% in 2025.
  • Outset Medical's Long-Term Deferred Tax stood at $223.4 million in 2023, then grew by 9.74% to $245.2 million in 2024, then rose by 6.29% to $260.6 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Long-Term Deferred Tax are $260.6 million (Q4 2025), $245.2 million (Q4 2024), and $223.4 million (Q4 2023).